Alfenta

Active Ingredient(s): Alfentanil
FDA Approved: * December 29, 1986
Pharm Company: * AKORN
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Alfenta Overview

Alfentanil (R-39209, trade name Alfenta, Rapifen in Australia) is a potent but short-acting synthetic opioid analgesic drug, used for anaesthesia in surgery. It is an analogue of fentanyl with around one-fourth to one-tenth the potency, one-third the duration of action, and an onset of action four times faster than that of fentanyl.[2] Alfentanil has a pKa of approximately 6.5, which leads to a very high proportion of the drug being uncharged at physiologic pH, a characteristi...

Read more Alfenta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alfentanil

Recent Alfenta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alfentanil
  • Injection: 0.5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Alfenta: (1 result)

Sorted by National Drug Code
  • 17478-067 Alfenta 500 ug/ml Intravenous Injection by Akorn

Other drugs which contain Alfentanil or a similar ingredient: (1 result)